Once considered rare, eosinophilic esophagitis (EoE) is now rapidly increasing in prevalence, making it a frequent challenge in gastroenterology, allergy, and even primary care. But with evolving research, how has diagnosis and treatment changed?
The latest American College of Gastroenterology guidelines highlight a shift in approach—moving beyond just symptom control to targeting both inflammation and fibrosis. Treatment now includes proton pump inhibitors, topical steroids, biologics, diet elimination, and esophageal dilation, with feeding therapy recommended for children.